DRUG · Unmapped registry intervention
Motexafin Gadolinium
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
NCT00054795
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Brain Neoplasmsverified · MONDO: brain neoplasm
Metastases, Neoplasmunresolved
Interventions
Sponsors & collaborators
Pharmacyclics LLC.lead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1San AntonioTexas, United States1NashvilleTennessee, United States1ClevelandOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00054795 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.